Company Directory / medical devices
PrivateFor profitmedical devicesSeattle, United States
Key Proteo
Key Proteo is a developer of a novel peptide screening for newborn babies.
- Founded
- 2019 7 years ago
- Staff
- 1-10 band, as listed
- Followers
- - on LinkedIn
- Funding
- $3.0M as listed, currency not stated
Set against six million companies
Size
1-10 people: larger than 0% of companies with a size listed
Age
7 years old.
Reach
No web traffic ranking listed.
What it does
Health DiagnosticsMedicalMedical Device
Funding, as listed
$3.0M currency not stated
- Rounds2
- LatestSeed, May 2023
- Investors1, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Key Proteo, field by field. Contact details are held but never shown.
The company
- Name
- Key Proteo
- Type
- For profit
- Status
- Private
- Founded
- 2019
- Founders
- Dr. Jae-Hoon Song, Dr. Steve (Sihoun) Hahn
- Industry
- medical devices
- Categories
- Health Diagnostics, Medical, Medical Device
Where
- City
- Seattle
- Country
- United States
- Markets
- Greater Seattle Area, West Coast, Western US
Size and reach
- Staff band
- 1-10
Funding, as listed
- Total
- 3,028,381 (currency not stated)
- Rounds
- 2
- Latest round
- Seed
- Latest round date
- May 2023
- Investors
- 1
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Key Proteo submitted a De Novo application to the FDA for its first newborn screening kit. Additionally, the company announced plans to establish a new CLIA-certified laboratory.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
medical devices in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.